Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 42

1.

Cannabinoid Receptor 2 Modulates Maturation of Dendritic Cells and Their Capacity to Induce Hapten-Induced Contact Hypersensitivity.

Gaffal E, Kemter AM, Scheu S, Leite Dantas R, Vogt J, Baune B, Tüting T, Zimmer A, Alferink J.

Int J Mol Sci. 2020 Jan 11;21(2). pii: E475. doi: 10.3390/ijms21020475.

2.

Production of IFNβ by Conventional Dendritic Cells after Stimulation with Viral Compounds and IFNβ-Independent IFNAR1-Signaling Pathways are Associated with Aggravation of Polymicrobial Sepsis.

Howe M, Bauer J, Schulze A, Kropp S, Locksley RM, Alferink J, Weighardt H, Scheu S.

Int J Mol Sci. 2019 Sep 7;20(18). pii: E4410. doi: 10.3390/ijms20184410.

3.

Social Defeat Modulates T Helper Cell Percentages in Stress Susceptible and Resilient Mice.

Ambrée O, Ruland C, Zwanzger P, Klotz L, Baune BT, Arolt V, Scheu S, Alferink J.

Int J Mol Sci. 2019 Jul 17;20(14). pii: E3512. doi: 10.3390/ijms20143512.

4.

Sources of Type I Interferons in Infectious Immunity: Plasmacytoid Dendritic Cells Not Always in the Driver's Seat.

Ali S, Mann-Nüttel R, Schulze A, Richter L, Alferink J, Scheu S.

Front Immunol. 2019 Apr 12;10:778. doi: 10.3389/fimmu.2019.00778. eCollection 2019. Review.

5.

Mitochondria, Microglia, and the Immune System-How Are They Linked in Affective Disorders?

Culmsee C, Michels S, Scheu S, Arolt V, Dannlowski U, Alferink J.

Front Psychiatry. 2019 Jan 9;9:739. doi: 10.3389/fpsyt.2018.00739. eCollection 2018. Review.

6.

Interferon β-Mediated Protective Functions of Microglia in Central Nervous System Autoimmunity.

Scheu S, Ali S, Mann-Nüttel R, Richter L, Arolt V, Dannlowski U, Kuhlmann T, Klotz L, Alferink J.

Int J Mol Sci. 2019 Jan 7;20(1). pii: E190. doi: 10.3390/ijms20010190. Review.

7.

CCL17 exerts a neuroimmune modulatory function and is expressed in hippocampal neurons.

Fülle L, Offermann N, Hansen JN, Breithausen B, Erazo AB, Schanz O, Radau L, Gondorf F, Knöpper K, Alferink J, Abdullah Z, Neumann H, Weighardt H, Henneberger C, Halle A, Förster I.

Glia. 2018 Oct;66(10):2246-2261. doi: 10.1002/glia.23507. Epub 2018 Sep 12.

PMID:
30277599
8.

Neurobiology of the major psychoses: a translational perspective on brain structure and function-the FOR2107 consortium.

Kircher T, Wöhr M, Nenadic I, Schwarting R, Schratt G, Alferink J, Culmsee C, Garn H, Hahn T, Müller-Myhsok B, Dempfle A, Hahmann M, Jansen A, Pfefferle P, Renz H, Rietschel M, Witt SH, Nöthen M, Krug A, Dannlowski U.

Eur Arch Psychiatry Clin Neurosci. 2019 Dec;269(8):949-962. doi: 10.1007/s00406-018-0943-x. Epub 2018 Sep 28.

PMID:
30267149
9.

Alterations of the Innate Immune System in Susceptibility and Resilience After Social Defeat Stress.

Ambrée O, Ruland C, Scheu S, Arolt V, Alferink J.

Front Behav Neurosci. 2018 Jul 13;12:141. doi: 10.3389/fnbeh.2018.00141. eCollection 2018.

10.

Identification of a novel Dlg2 isoform differentially expressed in IFNβ-producing plasmacytoid dendritic cells.

Ali S, Hoven A, Dress RJ, Schaal H, Alferink J, Scheu S.

BMC Genomics. 2018 Mar 12;19(1):194. doi: 10.1186/s12864-018-4573-5.

11.

Doxycycline inhibits experimental cerebral malaria by reducing inflammatory immune reactions and tissue-degrading mediators.

Schmidt KE, Kuepper JM, Schumak B, Alferink J, Hofmann A, Howland SW, Rénia L, Limmer A, Specht S, Hoerauf A.

PLoS One. 2018 Feb 13;13(2):e0192717. doi: 10.1371/journal.pone.0192717. eCollection 2018.

12.

The C-C Chemokines CCL17 and CCL22 and Their Receptor CCR4 in CNS Autoimmunity.

Scheu S, Ali S, Ruland C, Arolt V, Alferink J.

Int J Mol Sci. 2017 Nov 2;18(11). pii: E2306. doi: 10.3390/ijms18112306. Review.

13.

Altered B Cell Homeostasis in Patients with Major Depressive Disorder and Normalization of CD5 Surface Expression on Regulatory B Cells in Treatment Responders.

Ahmetspahic D, Schwarte K, Ambrée O, Bürger C, Falcone V, Seiler K, Kooybaran MR, Grosse L, Roos F, Scheffer J, Jörgens S, Koelkebeck K, Dannlowski U, Arolt V, Scheu S, Alferink J.

J Neuroimmune Pharmacol. 2018 Mar;13(1):90-99. doi: 10.1007/s11481-017-9763-4. Epub 2017 Sep 13.

PMID:
28905187
14.

Chemokine CCL17 is expressed by dendritic cells in the CNS during experimental autoimmune encephalomyelitis and promotes pathogenesis of disease.

Ruland C, Renken H, Kuzmanov I, Fattahi Mehr A, Schwarte K, Cerina M, Herrmann A, Otte DM, Zimmer A, Schwab N, Meuth SG, Arolt V, Klotz L, Förster I, Scheu S, Alferink J.

Brain Behav Immun. 2017 Nov;66:382-393. doi: 10.1016/j.bbi.2017.06.010. Epub 2017 Jun 19.

PMID:
28642092
15.

Prefrontal brain responsiveness to negative stimuli distinguishes familial risk for major depression from acute disorder.

Opel N, Redlich R, Grotegerd D, Dohm K, Zaremba D, Meinert S, Bürger C, Plümpe L, Alferink J, Heindel W, Kugel H, Zwanzger P, Arolt V, Dannlowski U.

J Psychiatry Neurosci. 2017 Sep;42(5):343-352.

16.

Attachment style moderates theory of mind abilities in depression.

Koelkebeck K, Liedtke C, Kohl W, Alferink J, Kret ME.

J Affect Disord. 2017 Apr 15;213:156-160. doi: 10.1016/j.jad.2017.02.021. Epub 2017 Feb 20.

PMID:
28236693
17.

Differential Abnormal Pattern of Anterior Cingulate Gyrus Activation in Unipolar and Bipolar Depression: an fMRI and Pattern Classification Approach.

Bürger C, Redlich R, Grotegerd D, Meinert S, Dohm K, Schneider I, Zaremba D, Förster K, Alferink J, Bölte J, Heindel W, Kugel H, Arolt V, Dannlowski U.

Neuropsychopharmacology. 2017 Jun;42(7):1399-1408. doi: 10.1038/npp.2017.36. Epub 2017 Feb 16.

18.

Alemtuzumab treatment alters circulating innate immune cells in multiple sclerosis.

Gross CC, Ahmetspahic D, Ruck T, Schulte-Mecklenbeck A, Schwarte K, Jörgens S, Scheu S, Windhagen S, Graefe B, Melzer N, Klotz L, Arolt V, Wiendl H, Meuth SG, Alferink J.

Neurol Neuroimmunol Neuroinflamm. 2016 Oct 12;3(6):e289. eCollection 2016 Dec.

19.

Cannabinoid Receptor 2 Modulates Susceptibility to Experimental Cerebral Malaria through a CCL17-dependent Mechanism.

Alferink J, Specht S, Arends H, Schumak B, Schmidt K, Ruland C, Lundt R, Kemter A, Dlugos A, Kuepper JM, Poppensieker K, Findeiss M, Albayram Ö, Otte DM, Marazzi J, Gertsch J, Förster I, Maier W, Scheu S, Hoerauf A, Zimmer A.

J Biol Chem. 2016 Sep 9;291(37):19517-31. doi: 10.1074/jbc.M116.746594. Epub 2016 Jul 29.

20.

Reduced locomotor activity and exploratory behavior in CC chemokine receptor 4 deficient mice.

Ambrée O, Klassen I, Förster I, Arolt V, Scheu S, Alferink J.

Behav Brain Res. 2016 Nov 1;314:87-95. doi: 10.1016/j.bbr.2016.07.041. Epub 2016 Jul 25.

PMID:
27469058

Supplemental Content

Loading ...
Support Center